- Report
- June 2025
- 101 Pages
Europe
From €3526EUR$3,950USD£3,085GBP
- Report
- March 2023
- 268 Pages
Global
From €4419EUR$4,950USD£3,866GBP
- Report
- September 2023
- 140 Pages
Europe
From €5312EUR$5,950USD£4,647GBP
- Report
- April 2024
- 115 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- June 2024
- 184 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- June 2024
- 182 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- May 2024
- 180 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- July 2024
- 158 Pages
Global
From €3794EUR$4,250USD£3,319GBP
- Report
- February 2024
- 110 Pages
China
From €4241EUR$4,750USD£3,710GBP
- Report
- January 2025
- 132 Pages
Global
From €848EUR$950USD£742GBP
- Report
- November 2024
- 83 Pages
United States
From €1076EUR$1,205USD£941GBP
The Companion Animal Drugs market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and distribution of drugs for companion animals, such as cats and dogs. These drugs are used to treat a variety of conditions, including infections, allergies, and chronic diseases. The market is driven by the increasing demand for pet healthcare services, as well as the growing number of pet owners. Additionally, the development of new drugs and treatments for companion animals has also contributed to the growth of the market.
The Companion Animal Drugs market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Zoetis, and Bayer Animal Health. Show Less Read more